TrialJAMA network open2024
Liraglutide for Lower Limb Perfusion in People With Type 2 Diabetes and Peripheral Artery Disease: The STARDUST Randomized Clinical Trial.
Paola Caruso et al.PubMed ↗Full text ↗Publisher ↗
The primary results report of NCT04881110. Its numbers are set against the trial’s posted results below.
No numbers read from the abstract.
Against the trial’s posted results
- Same as the trial’s posted resultThis paper difference 11.2 (8.00–14.5)Posted, primary outcome difference 11.2 (8.00–14.5), p <0.001Peripheral Transcutaneous Oxygen Pressure
- Same as the trial’s posted resultThis paper RR 1.91 (1.26–2.90)Posted, primary outcome RR 1.91 (1.26–2.90), p <0.001Peripheral Transcutaneous Oxygen Pressure
27 papers cite it
this paperpooled ittrialcites it